Table 3.
Outcomes | Intervention group (N = 619) | Control group (N = 619) | P |
---|---|---|---|
Primary outcome | |||
28-day mortality, no. (%) | 133 (21.5) | 168 (27.1) | 0.020 |
Secondary outcomes | |||
LOS [median (IQR)], days | |||
In ICU | 5.92 [3.64, 10.92] | 5.04 [3.23, 9.23] | 0.001 |
In hospital | 12.36 [7.86, 20.46] | 11.29 [6.81, 18.62] | 0.018 |
28-day cumulative mechanical ventilation–free days [median (IQR)], days | 26.23 [22.23, 27.54] | 26.60 [23.42, 28.00] | 0.002 |
28-day cumulative vasoactive agent–free days [median (IQR)], days | 26.75 [24.95, 27.56] | 26.10 [24.30, 27.17] | <0.001 |
28-day cumulative RRT–free days [median (IQR)], days | 28.00 [28.00, 28.00] | 28.00 [28.00, 28.00] | 0.685 |
Data are presented as mean ± SD or median (interquartile range) for skewed variables or proportions for categorical variables.
LOS, length of stay; IQR, interquartile range; ICU, intensive care unit; RRT, renal replacement therapy.